Iteos Therapeutics Inc (ITOS) Annual Balance Sheets

Annual · GAAP · USD millions
Access ITOS quarterly Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Iteos Therapeutics Inc adapts its asset base and funding mix.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Assets
Cash & cash equivalent142.13
Short-term Investments, Total352.52
Cash & Short-term Investments494.00
Grants Receivable, Current0.81
Other Current Assets2.89
Prepaid Expense And Other Assets Current11.20
Total Current Assets509.54
Equipment/Property/Plant Net4.90
Long-term investments160.35
Income Taxes Receivable PR1.92
Other Assets, Noncurrent7.00
Research And Development Tax Credit Receivable Current0.96
Research And Development Tax Credit Receivable Non Current5.91
Restricted Cash Noncurrent0.30
Total Assets686.98
Liabilities
Accounts Payable, Current AC8.50
Employee-related Liabilities, Current AC10.13
Other Liabilities, Current0.00
Unrecognized Tax Benefits46.72
Deferred Revenue DE0.00
Total Current Liabilities65.36
Total Long-term Debt0.00
Other liabilities, Noncurrent31.33
Accrued Clinical Trial Costs Current17.90
Deferred Income Current1.40
Grants Repayable5.84
Total Liabilities96.68
Stockholders' Equity
Common Stock Value0.04
Additional Paid In Capital Common Stock616.04
Retained Earnings / Accumulated Deficit-9.78
Other Equity-16.00
Common Stockholder's Equity590.29
Total Stockholder's Equity590.29
Liabilities & Stockholder's Equity686.98
4 historic quarters locked

Sign in to unlock the full Iteos Therapeutics Inc balance sheet history.

About Iteos Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-25-033066

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.